Evaxion announces nih grant for research collaboration with umass chan medical school

Copenhagen, denmark, sept. 06, 2022 (globe newswire) -- evaxion biotech a/s (nasdaq: evax) (“evaxion” or the “company”), announced today that the company, in collaboration with umass chan medical school (“umass chan”), has received a grant from the u.s. national institutes of health (“nih”) for the development of a gonorrhea lead vaccine candidate.

EVAX Ratings Summary

EVAX Quant Ranking